Summary Information:
Neurocrine Biosciences Inc. Common Stock
NASDAQ:NBIX


email
[email protected]
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


Neurocrine Biosciences Inc. Common Stock
Exchange: NASDAQ
Symbol: NBIX
SEC CIK: 0000914475
Phone: (858) 617-7600
12780 EL CAMINO REAL
SAN DIEGO CA 92130

CEO: Kevin Gorman
Price when page updated: 113.675 Date: 2023-12-01
Company Website:
www.neurocrine.com

_Description: Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company dedicated to discovering, developing and delivering life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company's diverse portfolio includes FDA-approved treatments for tardive dyskinesia, Parkinson's disease, endometriosis*, uterine fibroids* and clinical programs in multiple therapeutic areas. For nearly three decades, Neurocrine Biosciences has specialized in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.

IPO YEAR:
1996
Sector:
Health Care
Industry:
Biotechnology: Biological Products (No Diagnostic Substances)
ADRTSO:

MarketCap:
11168787347.00
Beta:
0.762820282641958
52 Week High:
120.27
52 Week Low:
78.31
52 Week Change:
-0.11556579085104156
Short Interest:

Short Date:

Shares Outstanding:
94866693
Dividend Rate:
0
Dividend Yield:
8.13%
ExDividend Date:

Latest EPS:

Latest EPS Date:
27 Oct 2022
Float:
0
return on Equity:
-99.00%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$4.564B
ttmEPS:
4.49
Revenue:
$25.476B
Gross Profit:

Cash:

Debt:

Institution Percent:
60.20%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.07%
Return on Assets:
4.50%
Return on Capital:

Profit Margin:
6.80%
Price to Sales:
3.26
Price To Book:
-
Short Ratio:
2.17
PE Ratio:
18.01997952241457
Employees:
845
1Y Guesstimate
N/A:N/A:N/A




__The following are links to various summary and news pages for
__Neurocrine Biosciences Inc. Common Stock [ NBIX ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01